Colorectal carcinoma screening in patients with type 2 diabetes mellitus;Diabetes mellitus typ 2 - Ein Risikofaktor für kolorektale karzinome: Review der evidenz und algorithmus für ein modifiziertes screening

Zeitschrift fur Gastroenterologie

Volumn 44, Issue 11, 2006, Pages 1153-1165

  Nagel, J M ^a   Göke, Burkhard ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Colorectal carcinoma; Diabetes mellitus; Insulin

Indexed keywords

INSULIN; SOMATOMEDIN; SULFONYLUREA DERIVATIVE;

CANCER CELL; CANCER GROWTH; CANCER INCIDENCE; CANCER SCREENING; CANCER SURVIVAL; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL CARCINOMA; GLUCOSE HOMEOSTASIS; HUMAN; HYPERINSULINEMIA; INSULIN TREATMENT; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW;

ALGORITHMS; COLORECTAL NEOPLASMS; COMORBIDITY; DIABETES MELLITUS, TYPE 2; HUMANS; MASS SCREENING; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PREVALENCE; RISK ASSESSMENT; RISK FACTORS;

EID: 33845417141     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-927132     Document Type: Review

References (83)

1. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin 1999; 49: 33-64
2. Reddy BS. Diet and excretion of bile acids. Cancer Res 1981; 41: 3766-3768
3. Chomchai C, Bhadrachari N, Nigro ND. The effect of bile on the induction of experimental intestinal tumors in rats. Dis Colon Rectum 1974; 17: 310-312
4. Narisawa T, Magadia NE, Weisburger JH et al. Promoting effect of bile acids on colon carcinogenesis after intrarectal instillation of N-methyl-N′-nitro-N-nitrosoguanidine in rats. J Natl Cancer Inst 1974; 53: 1093-1097
5. Yang R, Arem R, Chan L. Gastrointestinal tract complications of diabetes mellitus. Pathophysiology and management. Arch Intern Med 1984; 144: 1251-1256
6. Liu K, Stamler J, Moss D et al. Dietary cholesterol, fat, and fibre, and colon-cancer mortality. An analysis of international data. Lancet 1979; 2: 782-785
7. Alberts DS, Martinez ME, Roe DJ et al. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians' Network. N Engl J Med 2000; 342: 1156-1162
8. Fuchs CS, Giovannucci EL, Colditz GA et al. Dietary fiber and the risk of colorectal cancer and adenoma in women. N Engl J Med 1999; 340: 169-176
9. Sandhu MS, White IR, McPherson K. Systematic review of the prospective cohort studies on meat consumption and colorectal cancer risk: a meta-analytical approach. Cancer Epidemiol Biomarkers Prev 2001; 10: 439-446
10. Willett WC, Stampfer MJ, Colditz GA et al. Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. N Engl J Med 1990; 323: 1664-1672
11. Norat T, Lukanova A, Ferrari P et al. Meat consumption and colorectal cancer risk: dose-response meta-analysis of epidemiological studies. Int J Cancer 2002; 98: 241-256
12. Cross AJ, Pollock JR, Bingham SA. Haem, not protein or inorganic iron, is responsible for endogenous intestinal N-nitrosation arising from red meat. Cancer Res 2003; 63: 2358-2360
13. Calle EE, Rodriguez C, Walker-Thurmond K et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348: 1625-1638
14. Franco A, Sikalidis AK, Solis Herruzo JA. Colorectal cancer: influence of diet and lifestyle factors. Rev Esp Enferm Dig 2005; 97: 432-448
15. Giovannucci E. Insulin and colon cancer. Cancer Causes Control 1995; 6: 164-179
16. McKeown-Eyssen G. Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomarkers Prev 1994; 3: 687-695
17. Yang YX, Hennessy S, Lewis JD. Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. Gastroenterology 2004; 127: 1044-1050
18. Kune GA, Kune S, Watson LF. Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study. Cancer Res 1988; 48: 4399-4404
19. O'Mara BA, Byers T, Schoenfeld E. Diabetes mellitus and cancer risk: a multisite case-control study. J Chronic Dis 1985; 38: 435-441
20. Ragozzino M, Melton LJ III, Chu CP et al. Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. J Chronic Dis 1982; 35: 13-19
21. Hu FB, Manson JE, Liu S et al. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst 1999; 91: 542-547
22. Will JC, Galuska DA, Vinicor F et al. Colorectal cancer: another complication of diabetes mellitus? Am J Epidemiol 1998; 147: 816-825
23. Nilsen TI, Vatten LJ. Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis. Br J Cancer 2001; 84: 417-422
24. Le Marchand L, Wilkens LR, Kolonel LN et al. Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer. Cancer Res 1997; 57: 4787-4794
25. Limburg PJ, Anderson KE, Johnson TW et al. Diabetes mellitus and subsite-specific colorectal cancer risks in the Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev 2005; 14: 133-137
26. Yang YX, Hennessy S, Lewis JD. Type 2 diabetes mellitus and the risk of colorectal cancer. Clin Gastroenterol Hepatol 2005; 3: 587-594
27. La Vecchia C, Negri E, Decarli A et al. Diabetes mellitus and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 1997; 6: 1007-1010
28. Sandhu MS, Luben R, Knaw KT. Self reported non-insulin dependent diabetes, family history, and risk of prevalent colorectal cancer: population based, cross sectional study. J Epidemiol Community Health 2001; 55: 804-805
29. Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 2005; 97: 1679-1687
30. Khaw KT, Wareham N, Bingham S et al. Preliminary communication: glycated hemoglobin, diabetes, and incident colorectal cancer in men and women: a prospective analysis from the European prospective investigation into cancer-Norfolk study. Cancer Epidemiol Biomarkers Prev 2004; 13: 915-919
31. Schoen RE, Weissfeld JL, Kuller LH et al. Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps. Gastroenterology 2005; 129: 464-475
32. Ma J, Giovannucci E, Pollak M et al. A prospective study of plasma C-peptide and colorectal cancer risk in men. J Natl Cancer Inst 2004; 96: 546-553
33. Renehan AG, Zwahlen M, Minder C et al. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 2004; 363: 1346-1353
34. Bowker SL, Majumdar SR, Veugelers P et al. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin. Diabetes Care 2006; 29: 254-258
35. Bjork J, Nilsson J, Hultcrantz R et al. Growth-regulatory effects of sensory neuropeptides, epidermal growth factor, insulin, and somatostatin on the non-transformed intestinal epithelial cell line IEC-6 and the colon cancer cell line HT 29. Scand J Gastroenterol 1993; 28: 879-884
36. Watkins LF, Lewis LR, Levine AE. Characterization of the synergistic effect of insulin and transferrin and the regulation of their receptors on a human colon carcinoma cell line. Int J Cancer 1990; 45: 372-375
37. Bach LA, Rechler MM. Insulin-like growth factors and diabetes. Diabetes Metab Rev 1992; 8: 229-257
38. Soos MA, Whittaker J, Lammers R et al. Receptors for insulin and insulin-like growth factor-I can form hybrid dimers. Characterisation of hybrid receptors in transfected cells. Biochem J 1990; 270: 383-390
39. Flier JS, Usher P, Moses AC. Monoclonal antibody to the type I insulin-like growth factor (IGF-I) receptor blocks IGF-I receptor-mediated DNA synthesis: clarification of the mitogenic mechanisms of IGF-I and insulin in human skin fibroblasts. Proc Natl Acad Sci USA 1986; 83: 664-668
40. Macaulay VM. Insulin-like growth factors and cancer. Br J Cancer 1992; 65: 311-320
41. Moller DE, Flier JS. Insulin resistance - mechanisms, syndromes, and implications. N Engl J Med 1991; 325: 938-948
42. Geier A, Beery R, Haimshon M et al. Serum and insulin inhibit cell death induced by cycloheximide in the human breast cancer cell line MCF-7. In Vitro Cell Dev Biol 1992; 28A: 415-418
43. Valverde AM, Fabregat I, Burks DJ et al. IRS-2 mediates the antiapoptotic effect of insulin in neonatal hepatocytes. Hepatology 2004; 40: 1285-1294
44. Corleta HE, Capp E, Corleta OC. Insulin receptor tyrosine kinase activity in colon carcinoma. Braz J Med Biol Res 1996; 29: 1593-1597
45. Underwood LE, Thissen JP, Lemozy S et al. Hormonal and nutritional regulation of IGF-I and its binding proteins. Horm Res 1994; 42: 145-151
46. Katz LEL, Cohen P, Rosenfeld R. Clinical significance of IGF binding proteins. Endocrinologist 1995; 5: 36-43
47. Powell DR, Suwanichkul A, Cubbage ML et al. Insulin inhibits transcription of the human gene for insulin-like growth factor-binding protein-1. J Biol Chem 1991; 266: 18 868-18 876
48. Strasser-Vogel B, Blum WF, Past R et al. Insulin-like growth factor (IGF)-I and -II and IGF-binding proteins 1, 2, and 3 in children and adolescents with diabetes mellitus: correlation with metabolic control and height attainment. J Clin Endocrinol Metab 1995; 80: 1207-1213
49. Bang P, Nygren J, Carlsson-Skwirut C et al. Postoperative induction of insulin-like growth factor binding protein-3 proteolytic activity: relation to insulin and insulin sensitivity. J Clin Endocrinol Metab 1998; 83: 2509-2515
50. Baserga R. The insulin-like growth factor I receptor: a key to tumor growth? Cancer Res 1995; 55: 249-252
51. Vogelstein B, Fearon ER, Hamilton SR et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319: 525-532
52. Burgering BM, Medema RH, Maassen JA et al. Insulin stimulation of gene expression mediated by p21ras activation. EMBO J 1991; 10: 1103-1109
53. Jhun BH, Meinkoth JL, Leitner JW et al. Insulin and insulin-like growth factor-I signal transduction requires p21ras. J Biol Chem 1994; 269: 5699-5704
54. Koohestani N, Tran TT, Lee W et al. Insulin resistance and promotion of aberrant crypt foci in the colons of rats on a high-fat diet. Nutr Cancer 1997; 29: 69-76
55. Koohestani N, Chia MC, Pham NA et al. Aberrant crypt focus promotion and glucose intolerance: correlation in the rat across diets differing in fat, n-3 fatty acids and energy. Carcinogenesis 1998; 19: 1679-1684
56. Corpet DE, Peiffer G, Tache S. Glycemic index, nutrient density, and promotion of aberrant crypt foci in rat colon. Nutr Cancer 1998; 32: 29-36
57. Corpet DE, Jacquinet C, Peiffer G et al. Insulin injections promote the growth of aberrant crypt foci in the colon of rats. Nutr Cancer 1997; 27: 316-320
58. Tran TT, Medline A, Bruce WR. Insulin promotion of colon tumors in rats. Cancer Epidemiol Biomarkers Prev 1996; 5: 1013-1015
59. Tran TT, Gupta N, Goh T et al. Direct measure of insulin sensitivity with the hyperinsulinemic-euglycemic clamp and surrogate measures of insulin sensitivity with the oral glucose tolerance test: correlations with aberrant crypt foci promotion in rats. Cancer Epidemiol Biomarkers Prev 2003; 12: 47-56
60. Lee WM, Lu S, Medline A et al. Susceptibility of lean and obese Zucker rats to tumorigenesis induced by N-methyl-N-nitrosourea. Cancer Lett 2001; 162: 155-160
61. Dunn SE, Kari FW, French J et al. Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice. Cancer Res 1997; 57: 4667-4672
62. Wu Y, Yakar S, Zhao L et al. Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis. Cancer Res 2002; 62: 1030-1035
63. Colangelo LA, Gapstur SM, Gann PH et al. Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol Biomarkers Prev 2002; 11: 385-391
64. Coughlin SS, Calle EE, Teras LR et al. Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 2004; 159: 1160-1167
65. Meyerhardt JA, Catalano PJ, Haller DG et al. Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol 2003; 21: 433-440
66. Morikawa T, Kato J, Yamaji Y et al. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology 2005; 129: 422-428
67. Hardcastle JD, Chamberlain JO, Robinson MH et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348: 1472-1477
68. Kronborg O, Fenger C, Olsen J et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996; 348: 1467-1471
69. Mandel JS, Bond JH, Church TR et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993; 328: 1365-1371
70. Selby JV, Friedman GD, Quesenberry CP Jr et al. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992; 326: 653-657
71. Hawk ET, Levin B. Colorectal cancer prevention. J Clin Oncol 2005; 23: 378-391
72. Anderson ML, Pasha TM, Leighton JA. Endoscopic perforation of the colon: lessons from a 10-year study. Am J Gastroenterol 2000; 95: 3418-3422
73. Levin TR, Conell C, Shapiro JA et al. Complications of screening flexible sigmoidoscopy. Gastroenterology 2002; 123: 1786-1792
74. Schmiegel W, Pox C, Adler C et al. S3-guideline conference "Colorectal Cancer" 2004. Dtsch Med Wochenschr 2005; 130 (Suppl 1): S5-53
75. Smith RA, Cokkinides V, von Eschenbach AC et al. American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin 2002; 52: 8-22
76. Winawer SJ, Zauber AG, Ho MN et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993; 329: 1977-1981
77. Nelson DB, McQuaid KR, Bond JH et al. Procedural success and complications of large-scale screening colonoscopy. Gastrointest Endosc 2002; 55: 307-314
78. Dafnis G, Ekbom A, Pahlman L et al. Complications of diagnostic and therapeutic colonoscopy within a defined population in Sweden. Gastrointest Endosc 2001; 54: 302-309
79. Bowles CJ, Leicester R, Romaya C et al. A prospective study of colonoscopy practice in the UK today: are we adequately prepared for national colorectal cancer screening tomorrow? Gut 2004; 53: 277-283
80. Pickhardt PJ, Choi JR, Hwang I et al. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med 2003; 349: 2191-2200
81. Rockey DC, Paulson E, Niedzwiecki D et al. Analysis of air contrast barium enema, computed tomographic colonography, and colonoscopy: prospective comparison. Lancet 2005; 365: 305-311
82. Cotton PB, Durkalski VL, Pineau BC et al. Computed tomographic colonography (virtual colonoscopy): a multicenter comparison with standard colonoscopy for detection of colorectal neoplasia. JAMA 2004; 291: 1713-1719
83. Komninou D, Ayonote A, Richie JP Jr et al. Insulin resistance and its contribution to colon carcinogenesis. Exp Biol Med (Maywood) 2003; 228: 396-405